Avivagen Inc. Stock Analysis VIV.H.V

Avivagen, Inc. engages in the development and commercialization of products for livestock. The company is headquartered in Ottawa, Ontario. The firm is focused on developing and commercializing products for livestock, companion animal and human applications that enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. Its OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia.